Analgesic Effect of Subanesthetic Intravenous Ketamine in Refractory Neuropathic Pain: A Case Report

Pain Medicine

Volumn 11, Issue 6, 2010, Pages 946-950

  Elsewaisy, Osama ^a   Slon, Barry ^a   Monagle, John ^b  

^a Intern   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Chronic Idiopathic Axonal Polyneuropathy; Ketamine; Neuropathic Pain; NMDA Antagonists

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIAZEPAM; GABAPENTIN; IMMUNOGLOBULIN; KETAMINE; METHADONE; VENLAFAXINE; ANALGESIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CASE REPORT; CHRONIC IDIOPATHIC AXONAL POLYNEUROPATHY; CHRONIC PAIN; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HALLUCINATION; HUMAN; HYPESTHESIA; LOW DRUG DOSE; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PARESTHESIA; POLYNEUROPATHY; TREATMENT DURATION; ANTAGONISTS AND INHIBITORS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEURALGIA; PAIN, INTRACTABLE;

ANALGESICS; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; NEURALGIA; PAIN, INTRACTABLE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 77954439097     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00863.x     Document Type: Article

References (46)

1. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
2. Bridges D, Thompson S, Rice A. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87:14-26.
3. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006, 52:77-92.
4. Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo antagonism. Neuropharmacology 2006, 51:6-18.
5. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanaesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004, 5:263-76.
6. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain 1995, 64:283-92.
7. Fitzgibbon EJ, Hall P, Schroder C, Seely J, Viola R. Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: A strategy for conversion from parenteral to oral ketamine. J Pain Symptom Manage 2002, 23:165-71.
8. Jackson K, Ashby M, Martin P. " Burst" ketamine for refractory cancer pain: An open-label audit of 39 patients. J Pain Symptom Manage 2001, 22:834-43.
9. Jørum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-d-aspartate (NMDA) receptor antagonist ketamine-A double-blind, cross-over comparison with alfentanil and placebo. Pain 2003, 101:229-36.
10. Pud D, Eisenberg E, Spitzer A. The NMDA receptor antagonist amantidine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial. Pain 1998, 75:359-63.
11. Rabben T, Skjelbred P, Øye I. Prolonged analgesic effect of ketamine, an N-Methyl-D-Aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 1999, 289:1060-7.
12. Slatkin N, Rhiner M. Ketamine in the treatment of refractory cancer pain: Case report, rationale, and methodology. J Support Oncol 2003, 1:287-95.
13. Fallon M, Welsh J. The role of ketamine in pain control. Eur J Palliat Care 1996, 3:143-7.
14. Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence-based review. Anesth Analg 2003, 97:1730-40.
15. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacol 2006, 60:341-9.
16. Mcleod J, Tuck R, Pollard J, Cameron J, Walsh J. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984, 47:530-5.
17. Notermans N, Wokke J, Franssen H. Chronic idiopathic polyneuropathy presenting in middle or old age: A clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993, 56:1066-71.
18. Notermans N, Wokke J, van der Graaf Y. Chronic idiopathic axonal polyneuropathy: A five year follow up. J Neurol Neurosurg Psychiatry 1994, 57:1525-7.
19. Hughes RAC, Umapathi T, Gray IA. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004, 127:1723-30.
20. Erdmann PG, Teunissen LL, van Genderen FR. Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol Neurosurg 2007, 254:1204-11.
21. Pleasure DE. Advances in neuropathic pain. Arch Neurol 2003, 60:1524-35.
22. Mellion ML. Neuropathic pain. Med Health R I 2008, 91:8-11.
23. Truini A, Cruccu G. Pathophysiological mechanisms of neuropathic pain. Neurol Sci 2006, 27:179-83.
24. Bell RF, Eccleston C, Kalso E. Ketamine as an adjuvant to opioids for cancer pain. A qualitative systematic review. J Pain Symptom Manage 2003, 26:867-72.
25. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study. Pain 1994, 56:51-8.
26. Mercadente SS. Ketamine in cancer pain: An update. Palliat Med 1996, 10:225-31.
27. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivit H. Relief of postherpetic neuralgia with the NMDA receptor ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994, 58:347-55.
28. Eide P, Stubhaug A, Breivit H. Continuous subcutaneous administration of the NMDA receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain 1995, 61:221-9.
29. Clark J, Kalan G. Effective treatment of severe cancer pain of the head using low dose ketamine in an opiod tolerant patient. J Pain Symptom Manage 1995, 10:5.
30. Roytblat L, Korotkouchko A, Katz J. Postoperative pain: The effect of low dose ketamine in addition to general anaesthetic. Anesth Analg 1993, 77:1161-6.
31. Schmind R, Sandler A, Katz J. Use and efficacy of low dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes. Pain 1999, 18:61-7.
32. Fisher K, Hagen NA. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: A case report. J Pain Symptom Manage 1999, 18:61-4.
33. White P, Way W, Trevor A. Ketamine-Its pharmacology and therapeutic uses. Anaesthesiology 1982, 56:119-37.
34. Fine P. Low dose ketamine in the management of opiod non responsive terminal cancer pain. J Pain Symptom Manage 1999, 17:296-301.
35. Mitchell AC, Fallon MT. A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: Results of a double blind randomised controlled trial. Pain 2002, 97:275-82.
36. Kvarnström A, Karsten R, Quiding H, Emanuelsson BM, Gordh T. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol Scand 2003, 47:868-78.
37. Bell RF. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 1999, 83:101-4.
38. Hoffmann V, Coppejans H, Vercauteren M, Adriaemsen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994, 10:240-3.
39. Klepstad P, Borchgrevink PC. Four years treatment with ketamine and a trial of dextromethorpan in a patient with severe post-herpetic neuralgia. Acta Anaesthesiol Scand 1997, 41:422-7.
40. Øye I, Rabben T, Fagerlund TH. Analgesic effect of ketamine, an NMDA receptor antagonist, in a patient with neuropathic pain. J Norwegian Med Assoc 1996, 116:3130-2.
41. Sörensen J, Bengtsson A, Ahlner J. Fibromyalgia-Are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997, 24:1615-22.
42. Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med 2008, 9:253-8.
43. Oye I, Paulson O, Maurset A. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1992, 260:1209-14.
44. Kiefer RT, Rohr P, Ploppa A, Unertl K, Schwartzman RJ. Is high dose ketamine a therapeutic option for severe intractable complex regional pain syndrome? Anesthesiology 2003, 99:1008-16.
45. Malhotra AK, Pinals DA, Weingartner H. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers. Neuropsychopharmacology 1996, 14:575-91.
46. Curran HV, Monaghan L. In and out of the K-hole: A comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 2001, 96:749-61.